| Apo®-Doxepin is available in strengths of 10 mg, 25 mg, 50 mg,
75 mg, 100 mg, and 150 mg.
10 mg: Each pink-and-scarlet capsule, identified "APO 10",
contains doxepin 10 mg. Sodium: <1 mmol (0.06 mg).
25 mg: Each pink-and-blue capsule, identified "APO 25",
contains doxepin 25 mg. Sodium: <1 mmol (0.16 mg).
50 mg: Each flesh-coloured-and-pink capsule, identified "APO
50", contains doxepin 50 mg. Sodium: <1 mmol (0.32 mg).
75 mg: Each flesh-coloured capsule, identified "APO 75",
contains doxepin 75 mg. Sodium: <1 mmol (0.48 mg).
100 mg: Each flesh-coloured-and-blue capsule, identified "APO
100", contains doxepin 100 mg. Sodium: <1 mmol (0.63 mg).
150 mg: Each pink capsule, identified "APO 150", contains
doxepin 150 mg. Sodium: <1 mmol (0.95 mg).
Nonmedicinal ingredients:
For 10 mg capsules: colloidal silicon dioxide, croscarmellose sodium,
lactose, microcrystalline cellulose, stearic acid, and talc; capsule shell:
EEC amaranth, D&C Red No. 28, D&C Yellow No. 10, edible black ink (pharmaceutical
glaze, synthetic black iron oxide, FD&C Blue No. 2 Aluminum Lake, FD&C
Red No. 40 Aluminum Lake, FD&C Blue No. 1 Aluminum Lake, D&C Yellow
No. 10 Aluminum Lake; may contain: n-butyl alcohol, propylene glycol, SDA-3A
alcohol), FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, gelatin,
and titanium dioxide.
For 25 mg, 50 mg, and 150 mg capsules: colloidal silicon
dioxide, croscarmellose sodium, lactose, microcrystalline cellulose, stearic
acid, and talc; capsule shell: D&C Red No. 28, edible black ink:
black iron oxide (may contain: pharmaceutical glaze/shellac, n-butyl alcohol,
SDA-3A alcohol, ethyl alcohol, isopropyl alcohol, propylene glycol, FD&C
Red No. 40 Aluminum Lake, FD&C Blue No. 2 Aluminum Lake, FD&C Blue No.
1 Aluminum Lake, D&C Yellow No. 10 Aluminum Lake, ammonium hydroxide, potassium
hydroxide), FD&C Blue No. 1, FD&C Red No. 40, gelatin, silicon dioxide,
sodium lauryl sulfate, and titanium dioxide.
For 75 mg and 100 mg capsules: colloidal silicon dioxide, croscarmellose
sodium, lactose, microcrystalline cellulose, stearic acid, and talc; capsule
shell: D&C Red No. 28, D&C Yellow No. 10, edible black ink (pharmaceutical
glaze, synthetic black iron oxide, FD&C Blue No. 2 Aluminum Lake, FD&C
Red No. 40 Aluminum Lake, FD&C Blue No. 1 Aluminum Lake, D&C Yellow
No. 10 Aluminum Lake; may contain: n-butyl alcohol, propylene glycol, SDA-3A
alcohol), FD&C Blue No. 1, gelatin, sodium lauryl sulfate, silicon dioxide,
and titanium dioxide. |
Heart disease: Tricyclic
antidepressant drugs such as doxepin can cause abnormal
heart rhythms, particularly when taken in high doses. Doxepin should
be taken with caution by seniors as well as those who have a history of
heart disease.
Liver function: Doxepin should be taken with caution by people
with reduced liver function.
Mania: Doxepin may induce mania in people with a history of mania
or bipolar disorder.
Occupational hazards: Since doxepin may cause drowsiness, avoid
driving or engaging in activities requiring mental alertness and physical
coordination until you determine your response to the medication.
Seizures: Doxepin should
be taken with caution by anyone who has previously had seizures.
Withdrawal: Stopping doxepin treatment after having taken it for
a long period of time may produce nausea,
headache, and malaise. These
symptoms are not indicative of addiction. Do not stop taking doxepin suddenly
without first talking with your doctor.
Pregnancy: The safety of doxepin use during pregnancy has not
been established. It should not be used by women who are or may become
pregnant unless, in the opinion of their doctor, the potential benefits
outweigh the possible risks.
Breast-feeding: The safety of doxepin use while breast-feeding
has not been established. It should not be used by nursing women unless,
in the opinion of their doctor, the potential benefits outweigh the possible
risks.
Children: This medication is not recommended for use by children,
as its safety and efficacy have not been established for this age group.
|
The following medications may affect how doxepin works or increase
the risk of side effects:
- alcohol
- anticholinergic medications (e.g., atropine)
- barbiturates (e.g., phenobarbital)
- carbamazepine
- benzodiazepines (e.g., diazepam,
lorazepam)
- cimetidine
- quinidine
- MAO inhibitors (e.g., phenelzine,
moclobemide)
- methyldopa
- metoclopramide
- methylphenidate
- phenothiazines (e.g., chlorpromazine)
- pimozide
- propoxyphene
- SSRI antidepressants (e.g., fluoxetine,
fluvoxamine)
Doxepin may affect how the following medications work:
- amphetamines
- guanethidine
If you are taking any of these medications, speak with your doctor
or pharmacist. Depending on your specific circumstances, your doctor
may want you to:
- stop taking one of the medications,
- change one of the medications to another,
- change how you are taking one or both of the medications, or
- leave everything as is.
An interaction between two medications does not always mean that
you must stop taking one of them. In many cases, interactions are
intended or are managed by close monitoring. Speak to your doctor about
how any drug interactions are being managed or should be managed.
Medications other than the ones listed above may interact with this
medication. Tell your doctor or prescriber about all prescription,
over-the-counter (non-prescription), and herbal medications that you are
taking. Also tell them about any supplements you take. Since caffeine,
the nicotine from cigarettes, or street drugs can affect the
action of many medications, you should let your prescriber know if you
use them. |